XML 68 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
SEGMENT AND GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Dec. 31, 2012
SEGMENT AND GEOGRAPHIC INFORMATION [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
The following table shows revenue and income (loss) from operations by reportable operating segment for the years ended December 31, 2012 and 2011 (in thousands):
 
Year Ended December 31,
 
 
2012
 
 
2011
 
Revenue (a):
 
 
 
 
Affymetrix Core
 
$
235,105
 
 
$
242,307
 
eBioscience
 
 
37,011
 
 
 
-
 
Totals
 
$
272,116
 
 
$
242,307
 
Income (loss) from operations (a):
 
 
 
 
 
 
 
 
Affymetrix Core
 
$
35,230
 
 
$
55,659
 
eBioscience
 
 
(8,792
)
 
 
-
 
Totals
 
$
26,438
 
 
$
55,659
 
Reconciliation of Revenue and Income (Loss) from Operations from Segments to Consolidated [Table Text Block]
The following table reconciles total operating segment revenue and loss from operations to the accompanying Consolidated Statements of Operations
Year Ended December 31,
2012
2011
Total revenue from reportable operating segments
$
272,116
$
242,307
Other revenue (a)
23,507
25,167
Total revenue
$
295,623
$
267,474
Total income from operations from reportable operating segments
$
26,438
$
55,659
Other corporate expenses, net (b)
(65,529
)
(72,300
)
Total loss from operations
$
(39,091
)
$
(16,641
)
(a) Other revenue include field service revenue and royalty revenue
(b) Other corporate expenses, net include cost of goods sold directly associated with other revenue, research and development, corporate marketing, facilities and other separately-managed general and administrative expenses.
Schedule of segment reporting information, by region
The following table shows revenue and income (loss) from operations by reportable operating segment for the years ended December 31, 2012 and 2011 (in thousands):
 
Year Ended December 31,
 
 
2012
 
 
2011
 
Revenue (a):
 
 
 
 
Affymetrix Core
 
$
235,105
 
 
$
242,307
 
eBioscience
 
 
37,011
 
 
 
-
 
Totals
 
$
272,116
 
 
$
242,307
 
Income (loss) from operations (a):
 
 
 
 
 
 
 
 
Affymetrix Core
 
$
35,230
 
 
$
55,659
 
eBioscience
 
 
(8,792
)
 
 
-
 
Totals
 
$
26,438
 
 
$
55,659
 
Net property and equipment by major geographic areas
Net property and equipment, classified by major geographic areas in which the Company operates was as follows (in thousands):
Year Ended December 31,
2012
2011
Net property and equipment:
United States (1)
$
22,204
$
32,168
Singapore
4,260
6,022
Europe
1,770
1,059
Other countries
430
335
Total
$
28,663
$
39,583
(1) Included in the balance as of December 31, 2011 was the Company's West Sacramento facility that was reclassified to held-for-sale on the accompanying Consolidated Balance Sheets at an estimated fair value of $9.0 million at December 31, 2011.